These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28489571)

  • 1. Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.
    Cocchiola R; Romaniello D; Grillo C; Altieri F; Liberti M; Magliocca FM; Chichiarelli S; Marrocco I; Borgoni G; Perugia G; Eufemi M
    Oncotarget; 2017 Jun; 8(26):42560-42570. PubMed ID: 28489571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells.
    Cocchiola R; Rubini E; Altieri F; Chichiarelli S; Paglia G; Romaniello D; Carissimi S; Giorgi A; Giamogante F; Macone A; Perugia G; Gurtner A; Eufemi M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
    Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASC-J9
    Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C
    Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.
    Elguero B; Gueron G; Giudice J; Toscani MA; De Luca P; Zalazar F; Coluccio-Leskow F; Meiss R; Navone N; De Siervi A; Vazquez E
    Neoplasia; 2012 Nov; 14(11):1043-56. PubMed ID: 23226098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tSTAT3, pSTAT3
    Krzyzanowska A; Don-Doncow N; Marginean FE; Gaber A; Watson RW; Hellsten R; Bjartell A
    Prostate; 2019 May; 79(7):784-797. PubMed ID: 30905090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.
    Marrocco I; Altieri F; Rubini E; Paglia G; Chichiarelli S; Giamogante F; Macone A; Perugia G; Magliocca FM; Gurtner A; Maras B; Ragno R; Patsilinakos A; Manganaro R; Eufemi M
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
    Lumahan LEV; Arif M; Whitener AE; Yi P
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
    Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth.
    Kwan HY; Liu B; Huang C; Fatima S; Su T; Zhao X; Ho AHM; Han Q; Hu X; Gong RH; Chen M; Wong HLX; Bian Z
    Cell Death Dis; 2019 Sep; 10(9):637. PubMed ID: 31474764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
    Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
    Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt.
    Miyazaki T; Bub JD; Iwamoto Y
    Biochim Biophys Acta; 2008 Oct; 1782(10):593-604. PubMed ID: 18718531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
    Xiang P; Jin S; Yang Y; Sheng J; He Q; Song Y; Yu W; Hu S; Jin J
    Prostate; 2019 Jun; 79(9):1018-1031. PubMed ID: 31018021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines.
    Zhou W; Grandis JR; Wells A
    Br J Cancer; 2006 Jul; 95(2):164-71. PubMed ID: 16804520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.
    Chandra-Kuntal K; Singh SV
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1473-83. PubMed ID: 20959517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
    Izumi K; Fang LY; Mizokami A; Namiki M; Li L; Lin WJ; Chang C
    EMBO Mol Med; 2013 Sep; 5(9):1383-401. PubMed ID: 23982944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
    J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.